PBE icon

Invesco Biotechnology & Genome ETF
PBE

Overview Fund Activity

81 hedge funds and large institutions have $80.7M invested in Invesco Biotechnology & Genome ETF in 2019 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 16 increasing their positions, 23 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
81
Holders Change
+10
Holders Change %
+14.08%
% of All Funds
1.76%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
13
Increased
16
Reduced
23
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
UBS Group
UBS Group
Switzerland
+$4.38M
2
Citadel Advisors
Citadel Advisors
Florida
+$1.62M
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$594K
4
Janney Montgomery Scott
Janney Montgomery Scott
Pennsylvania
+$468K
5
CA
Calton & Associates
Florida
+$314K

Top Sellers

1
ACM
Arlington Capital Management
Illinois
-$12.8M
2
Wells Fargo
Wells Fargo
California
-$329K
3
Morgan Stanley
Morgan Stanley
New York
-$255K
4
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$255K
5
Stifel Financial
Stifel Financial
Missouri
-$145K
Name Holding Trade Value Shares
Change 		Shares
Change %
AA
76
Advisory Alpha
Michigan
$3.79K +$3.79K +75 New
AIP
77
Ameritas Investment Partners
Nebraska
$2K – – –
GT
78
Glenmede Trust
Pennsylvania
$362 – – –
JPLA
79
Joseph P. Lucia & Associates
New York
$238 +$238 +13,263 New
ACM
80
Arlington Capital Management
Illinois
– -$12.8M -271,368 Closed
AIC
81
Ameritas Investment Company
Nebraska
– -$38K -814 Closed
DWM
82
Doyle Wealth Management
Florida
– -$2K -50 Closed
HWM
83
Holloway Wealth Management
Florida
– -$9K – –
1 2 3
4